David Mark Slager insider trades: Oramed Pharmaceuticals (ORMP) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
30 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 6, 2014 | ORMP | ↑ Buy | 2,252 | $4.44 | $10K | See | Jun 10, 2014 (4d) |
| Mar 25, 2014 | ORMP | ↑ Buy | 75,000 | $10.62 | $797K | See | Mar 25, 2014 (0d) |
| Feb 6, 2014 | ORMP | ↑ Buy | 51,292 | $15.61 | $801K | See | Feb 6, 2014 (0d) |
| Jul 10, 2013 | ORMP | ↑ Buy | 6,630 | $7.40 | $49K | See | Jul 12, 2013 (2d) |
| Aug 7, 2012 | LGDI | ↑ Buy | 23,431,180 | $0.07 | $1.6M | See | Aug 8, 2012 (1d) |
| Jun 25, 2012 | LGDI | ↑ Buy | 22,640,725 | $0.10 | $2.3M | See | Jun 27, 2012 (2d) |
| Feb 22, 2012 | LGDI | ↓ Sell | 535,400 | $0.12 | $64K | Indirect | Feb 23, 2012 (1d) |
| Feb 17, 2012 | LGDI | ↓ Sell | 595,000 | $0.11 | $66K | Indirect | Feb 21, 2012 (4d) |
| Feb 15, 2012 | LGDI | ↓ Sell | 343,500 | $0.11 | $37K | Indirect | Feb 16, 2012 (1d) |
| Feb 13, 2012 | LGDI | ↓ Sell | 658,500 | $0.11 | $74K | Indirect | Feb 14, 2012 (1d) |
| Feb 9, 2012 | LGDI | ↓ Sell | 493,700 | $0.11 | $54K | Indirect | Feb 10, 2012 (1d) |
| Feb 7, 2012 | LGDI | ↓ Sell | 282,000 | $0.12 | $33K | Indirect | Feb 8, 2012 (1d) |
| Feb 3, 2012 | LGDI | ↓ Sell | 270,600 | $0.12 | $32K | Indirect | Feb 6, 2012 (3d) |
| Feb 1, 2012 | LGDI | ↓ Sell | 60,400 | $0.12 | $7K | Indirect | Feb 2, 2012 (1d) |
| Jan 30, 2012 | LGDI | ↓ Sell | 168,310 | $0.13 | $22K | Indirect | Jan 31, 2012 (1d) |
| Jan 26, 2012 | LGDI | ↓ Sell | 1,015,000 | $0.13 | $130K | Indirect | Jan 27, 2012 (1d) |
| Jan 24, 2012 | LGDI | ↓ Sell | 60,000 | $0.12 | $7K | Indirect | Jan 25, 2012 (1d) |
| Jan 20, 2012 | LGDI | ↓ Sell | 23,000 | $0.13 | $3K | Indirect | Jan 23, 2012 (3d) |
| Jan 18, 2012 | LGDI | ↓ Sell | 65,000 | $0.13 | $8K | Indirect | Jan 19, 2012 (1d) |
| Jan 12, 2012 | LGDI | ↓ Sell | 1,200 | $0.14 | $167 | Indirect | Jan 17, 2012 (5d) |
| Jan 11, 2012 | LGDI | ↓ Sell | 85,000 | $0.15 | $13K | Indirect | Jan 12, 2012 (1d) |
| Jan 6, 2012 | LGDI | ↓ Sell | 85,000 | $0.13 | $11K | Indirect | Jan 9, 2012 (3d) |
| Jan 4, 2012 | LGDI | ↓ Sell | 150,000 | $0.13 | $19K | Indirect | Jan 5, 2012 (1d) |
| Dec 30, 2011 | LGDI | ↓ Sell | 390,000 | $0.14 | $56K | Indirect | Jan 3, 2012 (4d) |
| Dec 28, 2011 | LGDI | ↓ Sell | 1,064,500 | $0.10 | $107K | Indirect | Dec 29, 2011 (1d) |
| Dec 23, 2011 | LGDI | ↓ Sell | 182,000 | $0.11 | $19K | Indirect | Dec 27, 2011 (4d) |
| May 25, 2010 | LGDI | ↑ Buy | 1,500 | $0.95 | $1K | Indirect | May 27, 2010 (2d) |
| May 24, 2010 | LGDI | ↑ Buy | 75,000 | $1.02 | $77K | Indirect | May 25, 2010 (1d) |
| May 13, 2010 | LGDI | ↑ Buy | 65,000 | $1.06 | $69K | Indirect | May 14, 2010 (1d) |
| Apr 21, 2010 | LGDI | ↑ Buy | 50,100 | $1.06 | $53K | Indirect | Apr 22, 2010 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ORMP insiders
Open-market trades in the last 12 months
About David Mark Slager's insider trades
David Mark Slager is a director at Oramed Pharmaceuticals (ORMP). Since Apr 21, 2010, David has reported 10 open-market purchases worth $5.8M and 20 sales worth $764K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (5 filings), grants and awards (3 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ORMP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.